Mr. Thompson, a patient with stage 4 chronic kidney disease, is experiencing persistent edema, reduced urine output, and increased fatigue. Which nursing intervention should be prioritized to address these symptoms and improve his overall condition?

B) Initiate a low-sodium diet to help reduce fluid retention.

A) Increase the dosage of his current antihypertensive medication.

B) Initiate a low-sodium diet to help reduce fluid retention.

C) Administer an additional dose of erythropoietin to manage anemia.

D) Encourage increased fluid intake to promote kidney perfusion.

A nurse is reviewing Mr. Thompson's recent lab results and clinical symptoms. Which intervention should the nurse prioritize to address Mr. Thompson's current condition?

D) Planning for immediate initiation of dialysis to address fluid overload.

A) Adjusting his antihypertensive medication regimen to better control his blood pressure.

B) Initiating dietary modifications to reduce protein intake and manage uremia.

C) Increasing the dosage of erythropoietin therapy to improve his anemia.

D) Planning for immediate initiation of dialysis to address fluid overload.

A nurse is reviewing the care plan for Mr. Thompson, who has been diagnosed with heart failure and presents with fluid overload. Which of the following nursing interventions is most important to implement when Mr. Thompson is placed on intravenous furosemide therapy?

C) Measure daily weights and monitor intake and output

A) Encourage increased fluid intake to prevent dehydration

B) Monitor blood pressure every 8 hours to assess for hypotension

C) Measure daily weights and monitor intake and output

D) Increase dietary potassium intake to prevent hypokalemia

A nurse is caring for Mr. Thompson, who has been started on oral potassium supplementation due to hypokalemia from furosemide therapy. Which of the following interventions is most important for the nurse to implement to safely manage Mr. Thompson's condition?

C) Assess Mr. Thompson's cardiac rhythm regularly for any arrhythmias.

A) Encourage Mr. Thompson to consume a diet high in potassium-rich foods.

B) Monitor Mr. Thompson's blood pressure closely for any signs of hypotension.

C) Assess Mr. Thompson's cardiac rhythm regularly for any arrhythmias.

D) Instruct Mr. Thompson to weigh himself daily and report a weight gain of more than 2 pounds in 24 hours.

Mr. Thompson, a patient with fluid overload and renal impairment, has been initiated on intravenous furosemide, resulting in diuresis and improved respiratory status. However, his blood pressure remains elevated, and he now presents with mild hypokalemia and a slight increase in serum creatinine. Considering these clinical findings, which nursing intervention is most appropriate to address his current health issues while minimizing potential complications?

B) Administer oral potassium supplements and monitor serum potassium and renal function closely.

A) Discontinue furosemide and initiate a potassium-sparing diuretic to manage hypokalemia and serum creatinine levels.

B) Administer oral potassium supplements and monitor serum potassium and renal function closely.

C) Initiate a fluid restriction protocol to prevent further renal impairment and manage hypertension.

D) Recommend the addition of a beta-blocker to manage hypertension and provide cardiac protection.

A nurse is caring for Mr. Thompson, who is experiencing worsening fatigue and mild confusion. His current treatment includes furosemide and potassium supplementation. Given his recent decline in renal function and low serum potassium level, which of the following actions would be the most appropriate nursing intervention?

B) Monitor Mr. Thompson's neurological status and report any changes immediately.

A) Encourage increased oral fluid intake to improve renal function.

B) Monitor Mr. Thompson's neurological status and report any changes immediately.

C) Administer a higher dose of furosemide to manage his hypertension more effectively.

D) Discontinue potassium supplementation to prevent hyperkalemia.

Mr. Thompson is experiencing worsening fatigue and mild confusion with a recent increase in serum creatinine and persistent hypertension. Which nursing intervention is most appropriate to address his current condition?

B) Monitor neurological status closely and report any significant changes to the healthcare provider.

A) Encourage increased oral fluid intake to promote kidney perfusion.

B) Monitor neurological status closely and report any significant changes to the healthcare provider.

C) Administer additional doses of furosemide to manage hypertension and fluid overload.

D) Withhold potassium supplementation until serum levels are within the normal range.

Mr. Thompson is experiencing peripheral edema and weight gain despite ongoing diuretic therapy. After the introduction of a low-dose calcium channel blocker and modification of his diuretic regimen, which of the following assessments should the nurse prioritize to evaluate the effectiveness and safety of the new treatment plan?

B) Assessing for signs of hyperkalemia, such as muscle weakness or arrhythmias.

A) Monitoring Mr. Thompson's blood glucose levels.

B) Assessing for signs of hyperkalemia, such as muscle weakness or arrhythmias.

C) Evaluating liver function tests to detect potential hepatotoxicity.

D) Checking for signs of digitalis toxicity, such as visual disturbances.

Mr. Thompson, a patient with persistent hypertension and peripheral edema, has been started on a low-dose calcium channel blocker and a potassium-sparing diuretic, spironolactone. His blood pressure shows slight improvement, but he experiences fatigue and mild confusion. Which of the following assessments should the nurse prioritize to evaluate the effectiveness and safety of the new medication regimen?

B) Evaluate serum potassium levels for signs of hyperkalemia.

A) Monitor daily weights to assess for fluid retention.

B) Evaluate serum potassium levels for signs of hyperkalemia.

C) Check for orthostatic hypotension to ensure blood pressure stability.

D) Assess neurological status for signs of worsening confusion.

chronic kidney disease progressing to kidney transplant - Nursing Case Study

Pathophysiology

• Primary mechanism: Chronic kidney disease (CKD) involves the progressive loss of nephrons due to sustained damage, often from diabetes or hypertension. This results in decreased glomerular filtration rate (GFR), leading to toxin accumulation and impaired fluid and electrolyte balance.

• Secondary mechanism: As nephron loss continues, increased pressure and workload on remaining nephrons cause hyperfiltration and further damage, creating a vicious cycle of nephron destruction and fibrosis.

• Key complication: End-stage renal disease (ESRD) occurs when kidney function declines to the point that homeostasis cannot be maintained, necessitating dialysis or a kidney transplant to replace lost renal function and sustain life.

Patient Profile

Demographics:

56-year-old male, accountant

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Kidney Disease Stage 3

• Current medications: Lisinopril, Metformin, Furosemide, Erythropoietin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in the legs

• Key symptoms: Shortness of breath, nausea, reduced urine output, pruritus

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 22 breaths/min, temperature 37.2°C (99.0°F), oxygen saturation 94% on room air

Section 1

As Mr. Thompson's chronic kidney disease progresses, his recent lab work and imaging provide crucial insights into his declining renal function. The latest blood tests reveal a serum creatinine level of 5.2 mg/dL and a blood urea nitrogen (BUN) of 60 mg/dL, indicating worsening renal insufficiency. His estimated glomerular filtration rate (eGFR) has fallen to 18 mL/min/1.73 m², signifying a transition to stage 4 CKD. An ultrasound of the kidneys shows bilateral atrophy with increased echogenicity, consistent with chronic renal parenchymal disease.

These findings are corroborated by worsening clinical symptoms. His blood pressure remains elevated despite antihypertensive therapy, suggesting possible medication adjustment or addition. The persistent edema and reduced urine output suggest fluid overload, a common complication at this stage. Furthermore, Mr. Thompson's hemoglobin level has dropped to 9.5 g/dL, leading to increased fatigue and necessitating potential adjustments in his erythropoietin therapy to manage anemia more effectively.

These developments underscore the urgency of preparing for renal replacement therapy, with the nephrology team discussing dialysis options while evaluating Mr. Thompson as a candidate for kidney transplantation. The multidisciplinary team considers optimizing his current treatment regimen to manage hypertension, diabetes, and anemia more effectively, aiming to stabilize his condition while awaiting transplantation. This phase necessitates careful monitoring and adjustments to prevent further complications and improve Mr. Thompson's quality of life as he approaches potential end-stage renal disease management.

Section 2

As Mr. Thompson continues under close observation, a new complication arises. During a routine clinic visit, he reports experiencing increased shortness of breath, particularly at night, and orthopnea. On examination, his vital signs reveal a blood pressure of 165/95 mmHg, heart rate of 92 beats per minute, and respiratory rate of 24 breaths per minute, with an oxygen saturation of 92% on room air. Auscultation of the lungs detects bilateral crackles, suggesting pulmonary congestion. His lower extremities show 3+ pitting edema, extending up to his knees.

The clinical team orders a chest X-ray, which reveals bilateral pleural effusions and pulmonary vascular congestion, indicating worsening fluid overload and possible heart failure. In response to these findings, a decision is made to initiate a more aggressive diuretic regimen to manage the fluid overload effectively. Mr. Thompson is started on intravenous furosemide to enhance diuresis, alongside meticulous monitoring of his electrolyte levels to prevent potential imbalances that could exacerbate his renal condition.

Simultaneously, the nephrology and cardiology teams work collaboratively to reassess his current antihypertensive and heart failure management strategies. Given the persistence of hypertension and fluid overload, adjustments to his medication regimen are considered, including the possible addition of a vasodilator or a beta-blocker to better control his blood pressure and alleviate cardiac strain. The evolving complexity of Mr. Thompson's condition highlights the critical need for ongoing multidisciplinary collaboration and dynamic treatment planning, ensuring that each therapeutic intervention aligns with both his renal and cardiovascular needs as he continues on the path towards kidney transplantation.

Section 3

As Mr. Thompson's condition is closely monitored following the initiation of intravenous furosemide, the clinical team observes a gradual diuresis with an increase in urine output. Over the next 48 hours, his weight decreases by 2.5 kilograms, and there is a noticeable reduction in the pitting edema of his lower extremities. His respiratory rate decreases to 20 breaths per minute, and his oxygen saturation improves to 95% on room air. However, his blood pressure remains elevated at 160/90 mmHg, and he continues to experience intermittent episodes of orthopnea, indicating that while the fluid overload is being managed, his cardiovascular status requires further intervention.

New laboratory results reveal a mild hypokalemia with a potassium level of 3.2 mmol/L, attributed to the enhanced diuretic therapy. The nephrology team decides to supplement potassium orally to prevent any cardiac complications associated with low potassium levels. Additionally, his serum creatinine level has slightly increased to 2.4 mg/dL from a baseline of 2.1 mg/dL, suggesting a delicate balance between managing fluid overload and maintaining renal function. The team discusses the potential need for adjusting his diuretic regimen and explores the possibility of incorporating a potassium-sparing diuretic to mitigate electrolyte imbalances.

Given these developments, the cardiology team proposes the introduction of a beta-blocker to address Mr. Thompson's persistent hypertension and provide cardiac protection. This addition is carefully considered, given his renal status, to ensure it does not adversely affect his kidney function. The collaborative approach aims to stabilize his cardiovascular and renal conditions, preparing him for the eventual kidney transplant. The team's focus remains on continually reassessing and fine-tuning his treatment plan, emphasizing the intricate interplay between his heart and kidney health.

Section 4

As Mr. Thompson continues to be closely monitored, the clinical team notes a concerning change in his status. Despite the initial improvements with fluid management, he begins to exhibit signs of worsening fatigue and mild confusion. These symptoms prompt the team to reassess his neurological status and conduct a thorough review of his current treatment regimen. His vital signs are stable except for persistent hypertension, recorded at 158/92 mmHg, and his heart rate remains elevated at 88 beats per minute. The team suspects that the combination of diuretic therapy and electrolyte imbalance may be contributing to his altered mental state.

New diagnostic results reveal a further decline in Mr. Thompson's renal function, with his serum creatinine level now at 2.7 mg/dL. This progression raises concerns about acute kidney injury on top of his chronic kidney disease, likely exacerbated by aggressive diuresis and potential under-replacement of potassium. Additionally, his serum potassium level has improved slightly to 3.4 mmol/L following supplementation but remains on the lower side. The nephrology team considers reducing the dose of furosemide and continues the potassium supplementation, while also evaluating the potential benefits of initiating a potassium-sparing diuretic to stabilize his electrolyte levels without compromising renal function further.

In response to these developments, the cardiology team re-evaluates the introduction of the beta-blocker, weighing the risks of potential renal impairment against the necessity of managing his hypertension and providing cardiac protection. This careful deliberation illustrates the complexities of Mr. Thompson's case, where every intervention must be balanced against the intricate interplay of his heart and kidney health. The collaborative effort aims to optimize his current condition, ensuring he remains a viable candidate for the anticipated kidney transplant. The team remains vigilant, ready to adjust the treatment plan as needed to address any new complications that may arise.

Section 5

As Mr. Thompson's case progresses, the team notes a new complication: the development of peripheral edema, particularly in his lower extremities. This swelling is accompanied by an increase in his weight, suggesting fluid retention despite ongoing diuretic therapy. His current weight reflects a gain of approximately 3 kilograms over the past week. The edema, coupled with his persistent hypertension, prompts the team to reassess his cardiovascular and fluid management strategies.

The nephrology team collaborates with cardiology to adjust his medication regimen, emphasizing the need to manage his blood pressure without exacerbating renal stress. The decision is made to introduce a low-dose calcium channel blocker, aiming to achieve better blood pressure control while minimizing potential nephrotoxic effects. Concurrently, the diuretic therapy is modified, with a cautious reduction of furosemide and the introduction of spironolactone, a potassium-sparing diuretic, to help address the electrolyte imbalance and fluid retention.

These interventions are closely monitored to evaluate their impact on Mr. Thompson's condition. Over the following days, his blood pressure shows a slight improvement, now averaging 150/88 mmHg, while his serum potassium level stabilizes at 3.8 mmol/L. The team remains vigilant for any signs of hyperkalemia due to the addition of spironolactone but is encouraged by the initial response. However, the persistence of fatigue and mild confusion indicates the need for continued observation and potential further adjustments. These developments underscore the delicate balance required in managing Mr. Thompson's complex medical needs as he moves closer to the prospect of a kidney transplant.